Antiretroviral treatment and expression of the mRNA levels for Pgp, MRP1, MRP4 and MRP5 in HIV antiretroviral naïve patients. Follow-up at 48 weeks by Falasca, Francesca et al.
POSTER PRESENTATION Open Access
Antiretroviral treatment and expression of the
mRNA levels for Pgp, MRP1, MRP4 and MRP5 in HIV
antiretroviral naïve patients. Follow-up at 48 weeks
Francesca Falasca
1, Francesca Graziano
1, Laura Antonelli
2, Paola Maida
1, Claudia Montagna
1, Bambina Rizzo
1,
Vincenzo Renda
2, Guido Antonelli
1, Ombretta Turriziani
1*
From 16
th International Symposium on HIV and Emerging Infectious Diseases
Marseille, France. 24-26 March 2010
Background
The ATP-binding cassette genes represent the largest
family of transmembrane proteins [including multidrug
resistant proteins (MRPs) and P-glycoprotein (Pgp)] able
to drive the transport of various molecules across cell
membranes. Several studies have demonstrated that
most of the above transporter are also able to transport
antiretrovirals.
The aim of this study was to evaluate whether the
antiretroviral treatment might affect the mRNA expres-
sion of Pgp and some MRPs.
Methods
Blood samples were collected from 13 HIV-positive
patients treatment naïve. After the beginning of the
treatment, samples were collected at 12, 24, 36 and
48 weeks. Eight patients were treated with Kaletra and
Truvada (group I) and five patients with Efavirenz and
NRTIs (truvada or combivir) (Gropu II). Expression of
mRNA of the Pgp, MRP1, MRP4, and MRP5 was evalu-
ated by real-time-PCR using the TaqMan technology
(ABI Prism 7000; Applied Biosystems).
Results
MDR1 and MRP4 expression was not affected by treat-
ment with PI and NRTI. In fact, at all time analyzed the
mRNA levels of these transporters did not significantly
differed from the mRNA levels detected before the begin-
ning of treatment. As far as MRP1 and MRP5 are con-
cerned, a modest, but not significant, reduction in the
mRNA expression levels was observed after beginning of
treatment. In patients belonging to the group II basically
the same results were obtained. Looking at the individual
trend of the mRNA expression of the above transporters
in each patient it can be seen that the expression levels of
these transporters seems to change during follow up but
it is independent of type and time of treatment. The
expression of the mRNA levels of these transporters
appears to increase in some patients and decrease in
other individuals suggesting that a high interindividual
variability in the modulation of these mRNA does exist.
Discussion
Antiretroviral treatment does not significantly affect the
expression levels of mRNA of transported analyzed. How-
ever an interindividual variability in the expression of
these mRNA has been documented during the follow up
and further studies are needed to evaluate whether the
over-expression of these mRNA may affect the success of
therapy.
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